key: cord-0823052-2mpz8wh3 authors: Li, Ziyi; Li, Cheng; Wu, Xinyin; Li, Guanming; Li, Guowei; Tian, Junzhang title: Development and application of a new framework for infectious disease management at the early stage of new epidemics: Taking COVID‐19 outbreak in China as an example date: 2021-04-01 journal: Int J Clin Pract DOI: 10.1111/ijcp.14174 sha: ce4aa6a38befec568d6e84a64de742e4254cbf7c doc_id: 823052 cord_uid: 2mpz8wh3 BACKGROUND: The outbreak of coronavirus disease 2019 (COVID‐19) rapidly spread across worldwide, posing a significant challenge to public health. Several shortcomings in the existing infectious disease management system were exposed during the pandemic, which hindered the control of the disease globally. To cope with this issue, we propose a window‐period framework to reveal the general rule of the progression of management of infectious diseases and to help with decision making at the early stage of epidemics with a focus on healthcare provisions. METHODS: The framework has two significant periods (dark‐window period and bright‐window period). Outbreak of COVID‐19 in China was used as an example for the application of the framework. RESULTS: The framework could reflect the progression of the epidemic objectively. The spread increased slowly in the dark‐window period, but rocketed up in the bright‐window period. The beginning of the bright‐window period was the time when healthcare personnel were exposed to a substantially high risk of nosocomial infection. Additionally, proper and prompt preventive actions during the dark‐window and bright‐window periods were substantially important to reduce the future spreading of the disease. CONCLUSIONS: It was recommended that when possible healthcare provisions should upgrade to the highest level of alert for the control of an unknown epidemic in the dark‐window period, while countermeasures in the bright‐window period could be accordingly adjusted with full exploration and considerations. The framework may provide some insights into how to accelerate the control of future epidemics promptly and effectively. The coronavirus disease 2019 , caused by a novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has spread across China and many other countries worldwide, 1 In China, the occurrence of COVID-19 cases dated back to early December 2019. 3 In retrospect, from December 2019 to early January 2020, more than 40 cases were reported. However, little was known about the pathogen and epidemiological characteristics of the disease at that moment; therefore, no prompt protective measures were taken in neither the majority of healthcare institutions nor communities by then. Since 16th January 2020, the number of daily confirmed cases started to rocket up, reaching the first peak on 4th February. Meanwhile, a large number of healthcare personnel were amongst the infected and/or suspected cases. Taken the 2-to-7-day incubation period into consideration, 4 the peak of transmission of SARS-CoV-2 was accordingly dated back to late January in China. Several shortcomings in the existing emergency management system for infectious disease were exposed during the pandemic, especially at the early stage. For example, defects included lack of rapid reaction to emerging infectious disease, failure to protect healthcare personnel, and insufficiency in medical resources in hospitals, to mention a few. The abovementioned issues hindered the control of the disease, not only in China, but in many other countries. To mitigate these issues, in this article, we propose a windowperiod framework with two significant periods (dark-window period and bright-window period, both at the early stage of an unknown epidemic), taking the outbreak of COVID-19 in China as an example. The term "window period" refers to the early stage of a new epidemic, while we cannot figure out the overall situation of the epidemic because of the lack of knowledge of the pathogen. Therefore we use the word "window" to reflect that our understanding would be largely restricted. The term "framework" indicates the structure of a system aiming to inform the decision making to control the epidemic of the disease. Our aim of proposing the framework is to reveal the general rule of the progression of management of infectious diseases and to help with decision making of rapid and targeted countermeasures at the early stage of new epidemics with a focus on healthcare provisions where, in general, the epidemic occurs initially, for the purpose of accelerating the control of future epidemics in a prompt and effective fashion. The framework was developed based on two rounds of consensus discussions of a panel of experts who were specialised in infectious disease, epidemiology, evidence-based medicine and hospital management. The framework we propose consists of four periods: pre-window period, dark-window period, bright-window period and post-window period. The start signs of each period are displayed in Figure 1 . We define the occurrence of a first new case with unknown pathogens as the initiation indicator of pre-window period. When there are two or more new cases that are epidemiologically and closely related to each other and with unknown pathogens appearing in the same hospital, the hospital is required to promptly In this article, we proposed a framework to reveal the general rule of the progression of management of infectious diseases and to help with decision making of rapid and targeted countermeasures at the early stage of new epidemics. F I G U R E 1 Proposed window-period framework document and report to the Chinese Centre for Disease Control and Prevention for further investigation. 5 This would place the authorities and hospitals on certain alert, albeit with unknown pathogens; therefore, it is considered as the start of dark-window period. During the dark-window period, it is the general practice to collect patients' biological specimen for laboratory and aetiological investigation. Until the pathogen is clearly identified, all the hospitals and authorities remain to be blind to the new epidemic. Consequently, we de- Of note, if the pathogen identified at the start of the brightwindow period is found non-novel and the disease can be under control with the existing services, the window-period scheme will terminate automatically at the end of the dark-window period and will be no longer applicable. Dates of the start sign of each period in the progress of COVID-19 in China were obtained from documents and reports of the National Centre for Disease Control and Prevention. Daily number of confirmed and suspected cases for the overall population in China were collected from daily reports of the National Health Commission of the People's Republic of China and previous published literature. 3, 6 The data were collected up to 11th February 2020, because the diagnostic criteria were substantially changed from 12th February on according to the Guidelines for the Diagnosis and Treatment of SARS-CoV-2 Infection (Trial Version 5). 7 In the Guidelines Version 5, patients with specific results from radiological examinations could be diagnosed as COVID-19, regardless of their nucleic acid test results. Therefore, such a change in criteria made the data before and after 12th February not comparable. Data and figures on infected healthcare personnel were gathered from the Chinese Centre for Disease Control and Prevention. 8 Descriptive analyses were used to illustrate the trend of daily confirmed, suspected, cured and dead cases in each period. To assess the transmissibility of COVID-19 in the framework, we conducted the analyses of time-dependent reproduction number (R t ) using the "EpiEstim" and "CoarseDataTools" packages in R (version 3.6.0; R Development Core Team, Vienna, Austria). To calculate the R t , we used the mean serial interval of COVID-19 as of 7.5 days with a standard deviation of 3.4 days, based on a previously published model. 3 As Table 1 shows, during the progression of COVID-19 in China, the start date of the bright-window period was 8th January 2020 when the pathogen was identified as a novel coronavirus that was and strong recommendations of strict regulations nationally. It thus turned out that the pre-window period lasted for 10 days, darkwindow period 28 days and bright-window period 19 days, respectively (Table 1) . Accumulative numbers of newly confirmed, suspected, cured and dead cases for the overall population stratified by the four periods in China are presented in Table 1 . The daily confirmed cases increased slowly in the per-and dark-window period, while there were 37 new cases confirmed during the dark-window period. Subsequently, the number started to soar during the bright-window period (Figure 2A We proposed a framework to help understand the process of emerging infectious disease, aiming to provide some insight into future sci- 156 000). 13 Second, isolation of all suspected and diagnosed cases at assembly sites was another important measure. One study suggested that home-based isolation may fail to effectively prevent both household and non-household transmissions of COVID-19. 14 Furthermore, prompt and rigorous isolation was linked to a reduction in the effective reproduction number of COVID-19. 14,15 These findings highlighted the significance of the rapid establishment of assembly sites. 16 To achieve this, Fangcang shelter hospitals could be one of the optimal options because of their rapid constructions, massive scales and low costs. 17 None. The data that support the findings of this study are available from the corresponding author upon reasonable request. https://orcid.org/0000-0003-1528-3931 A novel coronavirus from patients with pneumonia in China World Health Organization. COVID-19 Weekly Epidemiological Update Clinical features of patients infected with 2019 novel coronavirus in Wuhan Clinical characteristics of coronavirus disease 2019 in China National Health Commission of the People's Republic of China. National Scheme for Surveillance, Investigation and Management of Unexplained Pneumonia Cases National Health Commission of the People's Republic of China National Health and Health Commission of the People's Republic of China. Guidelines for the Diagnosis and Treatment of Novel Coronavirus. (2019-nCoV) Infection by the National Health Commission (Trial Version 8) Epidemiology Working Group for NCIP Epidemic Response. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China Correlation between travellers departing from Wuhan before the Spring Festival and subsequent spread of COVID-19 to all provinces in China Potential for global spread of a novel coronavirus from China An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China The engines of SARS-CoV-2 spread Reduction in effective reproduction number of COVID-19 is higher in countries employing active case detection with prompt isolation Institutional, not home-based, isolation could contain the COVID-19 outbreak Fangcang shelter hospitals: a novel concept for responding to public health emergencies Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel The effectiveness of full and partial travel bans against COVID-19 spread in Australia for travellers from China during and after the epidemic peak in China Global trends in air travel: implications for connectivity and resilience to infectious disease threats National Health Commission of the People's Republic of China. Daily Reports of COVID-19 Zero Infection in the Department Lead by Him Evaluation of the Surveillance System for pneumonia of unknown etiology: Chinese center for disease control and Prevention Development and application of a new framework for infectious disease management at the early stage of new epidemics: Taking COVID-19 outbreak in China as an example